Responses to weight loss treatment among obese individuals with and without BED: A matched-study meta-analysis
Psychology Department, St. John Fisher College, Rochester, NY 14618, USA. Eating and weight disorders: EWD
(Impact Factor: 0.79).
07/2007; 12(2):54-60. DOI: 10.1007/BF03327579
The moderating influence of binge eating status on obese individuals' responses to weight loss treatment was evaluated with a meta-analysis of 36 tests of weight loss treatment (n=792) that were matched to control key background variables. After controlling for pre-treatment weight, treatment produced more weight loss in samples of obese non-BED compared with obese BED participants. Weight loss treatment produced large posttreatment reductions in depression in both obese BED and non-BED samples. The results indicate that BED status moderated post-treatment weight loss among people in weight treatment programs. Obese BED (average weight loss=1.3 kg) samples lost negligible weight compared to obese non-BED (average weight loss=10.5 kg) samples. BED status did not moderate psychological responses to treatment: both BED and non-BED samples experienced large post-treatment reductions in depression. The clinical implications of these findings are discussed.
Available from: PubMed Central
- "They exhibit higher lifetime rates of affective disorder  and a lower quality of life [9, 10]. BED obese individuals undergoing weight loss treatment lose less weight than obese patients without BED . Taken together, these factors support the systematic screening of BED in people seeking a treatment for obesity . "
[Show abstract] [Hide abstract]
ABSTRACT: A significant percentage of obese patients suffer from binge eating disorder (BED), with negative consequences on psychological health, quality of life, weight loss treatment and maintenance. Cognitive behavioral therapy (CBT), delivered in traditional or self-help format, is effective in reducing BED symptoms. To improve dissemination, a self-help treatment program composed of eleven CBT based modules was implemented on the Internet and evaluated in a population of adult obese patients with BED.
Forty-two obese BED patients wait-listed for a multi-disciplinary obesity treatment took part in the study. Twenty-two patients completing the six-month online guided self-help treatment program were compared to a control group of twenty patients without intervention. Both groups were evaluated before and after six months of Internet self-help treatment or waiting list. A follow-up evaluation was carried out six months later.
Participants in the online self-help treatment program showed higher binge eating abstinence rates, lower EDE-Q shape and weight concerns, and improved TFEQ disinhibition of eating and hunger scores compared to the control group. They also scored better on psychological health and quality of life measures after intervention, and gains were maintained at follow-up. No effect was found regarding BMI. The number of modules completed was correlated with a better quality of life improvement at post evaluation. Participants rated the program as useful and easy to use.
The Internet seems to be a valuable tool for disseminating CBT for BED obese patients. Acceptance of new technology was good in this population. Further research is needed with a larger sample to corroborate these results.
[Show abstract] [Hide abstract]
ABSTRACT: Obesity is a chronic disease with multifactorial cause, associated with significant mortality and morbidity. It impacts every aspect of the patient's life. This review discusses the eating disorders that are related to obesity. Binge eating disorder is more frequently seen in obese patients, but bulimia nervosa/disordeed-eating behaviors have been included in the review as they can sometimes be associated with obesity However, it is important to note that most patients with bulimia tend to be of normal weight or overweight. The two disorders are reviewed with diagnostic criteria, risk factors, medical complications, evaluation and treatment recommendations. There is also a comparison between the two disorders. The essential key point is that eating disorders are impulse-control disorders and are similar to addictive behaviors in some aspects. It is essential to treat a patient with obesity and eating disorders multimodally to ensure success.
[Show abstract] [Hide abstract]
ABSTRACT: Le traitement médicamenteux des compulsions alimentaires chez le malade obèse est encore l’objet d’incertitudes. En effet,
si quelques études contrôlées sont disponibles, elles n’ont inclus que trop peu de malades au total. Les antidépresseurs de
type inhibiteurs de la recapture de la sérotonine, l’orlistat et les derniers anti-épileptiques ont fait la preuve de leur
efficacité (niveau de preuve: bon), mais aussi de leurs effets secondaires, en particulier les anti-épileptiques. Ces médicaments
ne sont efficaces en moyenne que chez un malade sur deux; ils n’agissent qu’après un délai d’au moins trois semaines et leurs
effets persistent tant que dure leur prise. La dose efficace est en règle élevée. Leurs effets favorables sont d’autant plus
importants et durent d’autant plus qu’un travail psychocomportemental a été effectué en parallèle.
The effectiveness of pharmacological treatment of compulsive eating disorders in obese patients is as yet uncertain. Although
some clinical trials have been carried out, not enough patients were involved in total. Antidepressants such as selective
serotonin reuptake inhibitors, orlistat and the newest anti-epileptics have all been shown to be successful (proof level:
good), but have also been seen to have side effects, particularly with respect to anti-epileptic drugs. On average, these
drugs only work for one in two patients, they take at least three weeks to work and they only work for as long as they are
being taken. They are generally only effective when taken in high doses. Their success is greater and more durable if used
simultaneously with psycho-behavioral therapy.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.